======= HMG20A =======
== Gene Information ==
* **Official Symbol**: HMG20A
* **Official Name**: high mobility group 20A
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10363|10363]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NP66|Q9NP66]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=HMG20A&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HMG20A|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605534|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Plays a role in neuronal differentiation as chromatin- associated protein. Acts as inhibitor of HMG20B. Overcomes the repressive effects of the neuronal silencer REST and induces the activation of neuronal-specific genes. Involved in the recruitment of the histone methyltransferase KMT2A/MLL1 and consequent increased methylation of histone H3 lysine 4 (By similarity). {ECO:0000250}.
|HMG box|
|negative regulation of protein sumoylation|
|regulation of protein sumoylation|
|negative regulation of protein modification by small protein conjugation or removal|
|negative regulation of neuron differentiation|
|regulation of protein modification by small protein conjugation or removal|
|negative regulation of neurogenesis|
|negative regulation of nervous system development|
|negative regulation of cell development|
|protein heterodimerization activity|
|negative regulation of protein modification process|
|regulation of neuron differentiation|
|DNA-binding transcription factor activity|
|chromatin organization|
|negative regulation of cell differentiation|
|regulation of neurogenesis|
|negative regulation of transcription by RNA polymerase II|
|regulation of nervous system development|
|regulation of cell development|
|negative regulation of developmental process|
|negative regulation of cellular protein metabolic process|
|chromosome organization|
|identical protein binding|
|negative regulation of protein metabolic process|
|negative regulation of transcription, DNA-templated|
|negative regulation of multicellular organismal process|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|generation of neurons|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|neurogenesis|
|negative regulation of gene expression|
|regulation of cell differentiation|
|regulation of protein modification process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp145|PNU96415E 10μM R03 exp145]]|-1.8|
|[[:results:exp211|AICAR 240μM R05 exp211]]|1.78|
|[[:results:exp264|Arsenate 40μM R06 exp264]]|2.53|
|[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|2.55|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15975
* **Expression level (log2 read counts)**: 5.8
{{:chemogenomics:nalm6 dist.png?nolink |}}